TCG News

TCG Launches the Swanson Fellowship Program and Dr. Tobias Schmid joins as first Fellow

Widely considered to be the father of the biotechnology industry, Robert Swanson changed the world when he founded Genentech with Herbert Boyer in 1976. TCG’s new fellowship program pays homage to Robert Swanson’s legacy, empowering the next generation of young visionaries on their quest to better the world through science and medicine.   The Column …

TCG Launches the Swanson Fellowship Program and Dr. Tobias Schmid joins as first Fellow Read More »

TCG Announces the Addition of TCG iPartners

TCG’s iPartners represents a new ideation advisory group comprised of leading academic investigators and biotech entrepreneurs. Working closely with TCG’s Swanson Fellows and our core investment team, this group is dedicated to crafting innovative new drug discovery company concepts, drawing on their deep scientific expertise, academic and industry networks, and entrepreneurial intuition. The iPartners consist …

TCG Announces the Addition of TCG iPartners Read More »

Dr. Eric Olson joins The Column Group as Science Partner

The Column Group announced the recruitment of Dr. Eric Olson to the firm’s renowned group of Science Partners. Dr. Olson is the founding Chair of the Department of Molecular Biology at The University of Texas Southwestern Medical Center. He also founded the Center for Regenerative Science and Medicine at UT Southwestern, which is advancing new …

Dr. Eric Olson joins The Column Group as Science Partner Read More »

Helen Hobbs, PhD

Dr. Helen Hobbs joins The Column Group as Science Partner

The Column Group announced the recruitment of Dr. Helen Hobbs to the firm’s renowned group of Science Partners. Dr. Hobbs is Professor of Internal Medicine and Molecular Genetics at the University of Texas Southwestern Medical Center. She is also an investigator at the Howard Hughes Medical Institute.

Scroll to Top